Also, it selectively reduces the levels of other cancer related IGFBP1 mRNA targets, including CDC34, BTRC, and COL5A, similar to the effect by knockdown of IGFBP1 in ovarian cancer cells [98]. The gene discussed is BTRC; the disease is ovarian cancer.